-
-
-
-
-
-
-
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
-
-
-
-
-
-
-
Gilead Sciences (GILD) PT Raised to $160 at Bernstein SocGen Group
-
-
-
-
-
-
-
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
-
-
-
-
-
-
-
Bernstein on Gilead Sciences (GILD): 'We Still Like This Story'
-
-
-
-
-
-
-
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
-
-
-
-
-
-
-
U.S. large biotech stocks Q2 earnings preview
-
-
-
-
-
-
-
What can get the U.S. large-cap pharma sector to work?
-
1,207,996 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

